These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35340407)

  • 21. Immunosuppressive Effects of Mesenchymal Stem Cells-derived Exosomes.
    Qian X; An N; Ren Y; Yang C; Zhang X; Li L
    Stem Cell Rev Rep; 2021 Apr; 17(2):411-427. PubMed ID: 32935222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
    Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
    Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MSCs-Derived Exosomes: Cell-Secreted Nanovesicles with Regenerative Potential.
    Marote A; Teixeira FG; Mendes-Pinheiro B; Salgado AJ
    Front Pharmacol; 2016; 7():231. PubMed ID: 27536241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Therapy, Preclinical and Clinical Evidence.
    Kiaie N; Ghanavati SPM; Miremadi SS; Hadipour A; Aghdam RM
    Int J Stem Cells; 2021 Aug; 14(3):252-261. PubMed ID: 34158414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential.
    Xiong J; Bao L; Qi H; Feng Z; Shi Y
    Curr Stem Cell Res Ther; 2021; 16(2):105-108. PubMed ID: 32479246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction.
    Safari A; Lionetti V; Razeghian-Jahromi I
    Stem Cell Res Ther; 2021 Jul; 12(1):404. PubMed ID: 34266486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
    Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
    Front Immunol; 2020; 11():54. PubMed ID: 32117234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cells.
    Hernandez JJ; Beaty DE; Fruhwirth LL; Lopes Chaves AP; Riordan NH
    J Transl Med; 2021 Apr; 19(1):149. PubMed ID: 33853637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome.
    Tovar I; Guerrero R; López-Peñalver JJ; Expósito J; Ruiz de Almodóvar JM
    Cells; 2020 Sep; 9(9):. PubMed ID: 32887260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current Clinical Application of Mesenchymal Stem Cells in the Treatment of Severe COVID-19 Patients: Review.
    Adugna DG
    Stem Cells Cloning; 2021; 14():71-80. PubMed ID: 34785907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists.
    Steckelings UM; Sumners C
    Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol.
    Kirkham AM; Monaghan M; Bailey AJM; Shorr R; Lalu MM; Fergusson DA; Allan DS
    Syst Rev; 2021 Sep; 10(1):249. PubMed ID: 34526123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current Knowledge and Future Perspectives on Mesenchymal Stem Cell-Derived Exosomes as a New Therapeutic Agent.
    Joo HS; Suh JH; Lee HJ; Bang ES; Lee JM
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities.
    Hassanzadeh A; Rahman HS; Markov A; Endjun JJ; Zekiy AO; Chartrand MS; Beheshtkhoo N; Kouhbanani MAJ; Marofi F; Nikoo M; Jarahian M
    Stem Cell Res Ther; 2021 May; 12(1):297. PubMed ID: 34020704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal stem cell therapy for COVID-19.
    Sengul F; Ozturk B; Vatansev H
    Am J Stem Cells; 2021; 10(5):79-89. PubMed ID: 35103115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections.
    Chrzanowski W; Kim SY; McClements L
    Front Bioeng Biotechnol; 2020; 8():554. PubMed ID: 32574317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Taming of Covid-19: potential and emerging application of mesenchymal stem cells.
    Najafi-Ghalehlou N; Roudkenar MH; Langerodi HZ; Roushandeh AM
    Cytotechnology; 2021 Apr; 73(2):253-298. PubMed ID: 33776206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different kinds of stem cells in the development of SARS-CoV-2 treatments.
    Mata-Miranda MM; Sanchez-Brito M; Vazquez-Zapien GJ
    World J Stem Cells; 2021 May; 13(5):439-451. PubMed ID: 34136074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.